版本:
中国

BRIEF-Molecular Partners: additional details about clinical oncology program MP0250

Oct 10Molecular Partners AG :

* Announced on Sunday additional details about its ongoing clinical oncology program MP0250

* Based on the encouraging data from phase 1 in solid tumors, Molecular Partners decided to initiate an additional phase 2 study for a solid tumor indication

* Study details will be disclosed in H1 2017

Source text for Eikon:

Further company coverage:

(Gdynia Newsroom)

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐